AOD-9604 for Fat Loss
Modified HGH fragment 176-191 analog targeted at fat loss without GH side effects.
Why AOD-9604 for fat loss?
AOD-9604 is the C-terminal fragment of HGH (residues 177–191) plus a tyrosine. Investigated for obesity in Phase 2 trials; TGA-listed as a complementary medicine in Australia.
Fat Loss context: Reducing body fat percentage through appetite regulation, lipolysis, or metabolic upregulation. AOD-9604 fits this goal because its category (Metabolic) and benefit profile align with the underlying mechanism.
Benefits relevant to fat loss
- Targets stubborn fat
- Stimulates lipolysis
Reference dosing by bodyweight
Anchored to the most-cited research dose (300 mcg @ 75 kg). Reference only.
| Bodyweight band | Reference dose range |
|---|---|
| <60 kg / <132 lb | 187–253 mcg |
| 60–75 kg / 132–165 lb | 230–311 mcg |
| 75–90 kg / 165–198 lb | 281–379 mcg |
| 90–105 kg / 198–231 lb | 332–448 mcg |
| >105 kg / >231 lb | 383–518 mcg |
Side effects to weigh against fat loss benefit
- Mild injection-site reaction
- Headache (rare)
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.